Ibrance (Palbociclib) is used for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy.
- You cannot add "Spiriva 18mcg inhalation Powder Combo Pack x 30" to the basket because the product is out of stock.
POM
In Stock
Ibrance 125mg x 21Caps (Pfizer)
Palbociclib
₦1,250,000.00
Bestsellers
POM
POM
POM
POM
POM
POM
POM
